Searched for
FOPE
PMO acts on pharma MSMEs 'crisis call'The PMO has been alerted to potential medicine shortages and price increases due to stringent regulatory actions on pharmaceutical quality....- Drug, medtech companies fear GST changes may squeeze fundsPharma and medtech sectors are concerned about upcoming Goods and Services Tax changes. They anticipate higher operating costs and working ...
- Stricter shelf life rule a bitter pill to swallow for pharma companiesA new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the I...
- Pharma companies may lose licence if drugs fail testsThe health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...
- Russia-Ukraine war: Indian pharma firm caught in crossfire, lobby seeks PM Modi’s helpAn Indian pharmaceutical company, Kusum Healthcare, operating in Ukraine, suffered significant damages after a warehouse was reportedly str...
- Pharma companies may get time till December to comply with schedule M normsThe govt may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notificati...
- Pharma lobby seeks 2-year extension of schedule M deadlinePharma lobby group FOPE has requested the government to extend the compliance deadline for the revised Schedule M till December 31, 2026. T...
- Centre may decide on rollout of Schedule M by next weekThe government is set to decide on implementing the revised Schedule M for pharmaceutical products by next week. While pharma groups have r...
- Karnataka HC stays action against drug units making NutraceuticalsThe Karnataka High Court has provided temporary relief to pharmaceutical companies by directing the government not to act against firms pro...
- Pharma companies seek more time to implement revised norms on manufacturing practicesSchedule M of the Drugs and Cosmetics Rules, 1945 prescribes the good manufacturing practices (GMP) for pharmaceutical products, such as a ...
- Pharma industry seeks relief from price cap rule for cheap drugsIndia’s FoPE seeks a 10-year exemption for patented and low-cost drugs from price controls. Requests include DPCO and 12% GST adjustments d...
- Pharma industry raises concerns over new Schedule M's impact on cosmetic manufacturingThe pharmaceutical industry, represented by the Federation of Pharma Enterprises (FoPE), has expressed concerns over the government's new S...
- Panel to examine if nutraceuticals can be produced within drug unitIn a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of ...
- Govt expands committee for drug and medical device pricing reforms, includes more industry representationThe government has expanded a committee to include more industry representation for reviewing drug and medical device pricing reforms. This...
- Lens on cos making drugs, supplements in same facility: Pharma body hopeful of a rethink on govt actionIn a recent diktat, the government said action will be taken against pharma units that are flouting the norms by manufacturing nutraceutica...
- Pharma companies producing drugs, supplements in same unit under lensThe government, DCGI, and state authorities are cracking down on pharma units manufacturing nutraceuticals, health supplements, and drugs i...
- FOPE urges pause on NPPA notice, citing potential losses for pharma industryFOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the pr...
- Pharma companies seek hike in drug rates under price controlChinese API imports turn 200% costlier, making production costlier in India. Over 70% of the country’s total bulk drug requirement comes fr...
- Drug makers body says government's ban 'arbitrary and unfair'Terming the decision to ban 344 fixed dose combination medicines as "arbitrary and unfair", pharma industry has said it feels let down by t...
- Excise-free states lose biz on duty cutThe excise duty incentives announced in this year’s budget may have been welcomed by the industry, but it has spelt doom for excise free zo...
Load More
